News

SYNERGIES: Conference stream and guidance are available online

Published on | 3 years ago

Programmes Horizon Europe HorizonEU L+F Digital Europe

SYNERGIES2022 conference

The Conference on Synergies in the Research and Innovation Funding in Europe, took place from Thursday, 7th July to Friday 8th July 2022 in Prague, Czechia.

The stream of the conference has been uploaded at the YouTube channel of the Ministry of Education, Youth and Sports of the Czech Republic: SYNERGIES2022

Synergies guidance is out

The Commission has published a practical and user-friendly guidance on new opportunities to maximise the synergies between Horizon Europe and the European Regional Development Fund programmes, which can be found here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1759 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.